X0306 4 2018-01-31 0 0000860730 HCA Healthcare, Inc. HCA 0001478415 Sowell Joseph A III ONE PARK PLAZA NASHVILLE TN 37203 0 1 0 0 SVP; Chief Development Officer Common Stock 2018-02-01 4 S 0 13365 100.7592 D 22216 D Common Stock 2018-02-01 4 S 0 16830 101.2306 D 5386 D Common Stock 8000 I By Trust (Reporting Person, Trustee) Stock Appreciation Right 101.16 2018-01-31 4 A 0 22870 0.00 A 2019-01-31 2028-01-31 Common Stock 22870 22870 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.33 to $101.04, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.065 to $101.5901, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. /s/ Natalie Harrison Cline, Attorney-in-Fact 2018-02-02